Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Latent Tuberculosis Infection Detection Market Size, Trends, Analysis, and Outlook By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), By Application (Household Contacts with Pulmonary TB, PLHIV, Others), By End-user (Diagnostic Laboratories, Hospitals/clinics, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030
... Hospitals/clinics, Academic & Research Institutions), by Region, Country, Segment, and Companies, 2024-2030 The global Latent Tuberculosis Infection Detection market size is poised to register 5.72% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Infectious Respiratory Disease Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Region, Blood, Others), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030
... Tuberculosis, Streptococcus Testing, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By End-User (Hospitals, Diagnostic Laboratories, Physician Offices, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Respiratory Disease Diagnostics market size is ... Read More
-
Tuberculosis Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Tuberculosis Therapeutics market size is poised to register 5.24% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Zoonotic Disease Treatment Market Size, Trends, Analysis, and Outlook By Type (Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Others), By Causative Agent (Bacteria, Virus, Nematode, Rodents, Ticks, Others), By Drug Class (Anti-fungal, Anti-bacterial, Antibiotics, Others), By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Zoonotic Disease ... Read More
-
Computer-Aided Detection Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Neurological/musculoskeletal/cardiovascular Indications), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030
... imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Computer-Aided Detection market size is poised to register 6.57% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
BCG Vaccine Market Size, Trends, Analysis, and Outlook By Product (Immune BCG, Therapy BCG), By Age Group (Paediatrics, Adults), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global BCG Vaccine market size is poised to register 6.77% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global BCG ... Read More
-
Bovine Tuberculosis Diagnosis Market Size, Trends, Analysis, and Outlook By Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests), by Region, Country, Segment, and Companies, 2024-2030
... to register 4.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Bovine Tuberculosis Diagnosis market across By Test Type (Serological Tests, Molecular ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Trends, Analysis, and Outlook By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing Chest X-Rays
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Treatment Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
... units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has ... Read More
-
Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
... The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected treach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising ... Read More
-
Middle East & Africa Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Middle East & Africa bovine diagnostics market is expected to ... Read More
-
Asia Pacific Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Asia Pacific bovine diagnostics market is expected to grow from US$ 250.42 ... Read More
-
Europe Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Europe bovine diagnostics market is expected to grow from US$ 301.31 million in ... Read More
-
South & Central America Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The South & Central America bovine diagnostics market is expected to ... Read More
-
North America Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The North America bovine diagnostics market is expected to grow from US$ 443.82 ... Read More
-
Tuberculosis Diagnostics Test Market - By Test Type (Radiographic, Diagnostic Laboratory, Molecular Diagnostics, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Phage Assay), End-use - Global Forecast, 2024 - 2032
... Diagnostics Test Market will witness over 5.5% CAGR between 2024 and 2032, spurred by increased availability and efforts to enhance the affordability of these diagnostics. With tuberculosis remaining a global health concern, there is a ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Global Forecast 2024-2030
... and expected to reach USD 2.76 billion in 2024, at a CAGR 7.38% to reach USD 4.23 billion by 2030. Global Tuberculosis Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
Research Assistance
